Jihun Ahn

Dr. Jihun Ahn


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
BCByoung Geol Choi
Byoung Geol Choi
SPSung Hun Park
Sung Hun Park
SRSeung-Woon Rha
Seung-Woon Rha
JAJihun Ahn
Jihun Ahn
SCSe Yeon Choi
Se Yeon Choi
DODong Joo Oh
Dong Joo Oh

25 June 2016 in Trials
Verified
Journal Article
Open access
PDF file
WCWoong Gil Choi
Woong Gil Choi
SISENS-ILIAC Investigators
SENS-ILIAC Investigators
SRSeung-Woon Rha
Seung-Woon Rha
CCCheol Ung Choi
Cheol Ung Choi
EKEung Ju Kim
Eung Ju Kim
JJJi Yong Jang
Ji Yong Jang
The self-expandable COMPLETE™ stent (Medtronic) has greater elasticity, allowing it to regain its shape after the compression force reduces, and has higher trackability, thus is easier to maneuver through tortuous vessels, whereas the balloon-expandable SCUBA™ stent (Medtronic) has higher radial stiffness and can afford more accurate placement without geographic miss, which is important in aortoiliac bifurcation lesions. To date, there have been no randomized control trials comparing efficacy and safety between the self-expanding stent and balloon-expandable stent in advanced atherosclerotic iliac artery disease. The purpose of our study is to examine primary patency (efficacy) and incidence of stent fracture and geographic miss (safety) between two different major representative stents, the self-expanding nitinol stent (COMPLETE-SE™) and the balloon-expanding cobalt-chromium stent (SCUBA™), in stenotic or occlusive iliac arterial lesions. This trial is designed as a prospective, randomized, multicenter trial to demonstrate a noninferiority of SCUBA™ stent to COMPLETE-SE™ stent following balloon angioplasty in iliac arterial lesions, and a total of 280 patients will be enrolled. The primary end point of this study is the rate of primary patency in the treated segment at 12 months after intervention as determined by catheter angiography, computed tomography angiography, or duplex ultrasound. The SENS-ILIAC trial will give powerful insight into whether the stent choice according to deployment mechanics would impact stent patency, geographic miss, or stent fracture in patients undergoing stent implantation in iliac artery lesions. National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier: NCT01834495 ), registration date: May 8, 2012


1 January 2025 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
KKKyung-A Kim
Kyung-A Kim
MKMin-Soo Kang
Min-Soo Kang
BCByoung Geol Choi
Byoung Geol Choi
JAJihun Ahn
Jihun Ahn
WKWonho Kim
Wonho Kim
MCMyung-Ae Chung
Myung-Ae Chung
Kim KA, et al. Yonsei Med J. 2025 Jan;66:e23. https://doi.org/10.3349/ymj.2024.0067

23 May 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
JAJihun Ahn
Jihun Ahn
SRSeung-Woon Rha
Seung-Woon Rha
BCByoung Geol Choi
Byoung Geol Choi
SCSe Yeon Choi
Se Yeon Choi
JBJae Kyeong Byun
Jae Kyeong Byun
HYHyeYon Yu
HyeYon Yu
Background: Successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is known to be associated with improved clinical outcomes compared with failed CTO PCI. However, it is not clear whether the angiographic and clinical outcomes of long CTO lesionis different with those of short CTO lesion in the drug eluting stent (DES) era. Method sand Results: A total of 235 consecutive patients underwent successful CTO intervention were divided into two groups according the CTO lesion length. Six-month angiographic and two-year clinical outcomes were compared between the two groups. The baseline clinical characteristics were similar between the two groups except prior PCI was more frequent in long CTO group whereas bifurcation lesion was more frequent in the short CTO group. In-hospital complications were similar between the two groups except intimal dissection was more frequent in long CTO group. Both groups had similar angiographic outcomes at 6 months and clinical outcomes up to 2 years except the incidence of repeat PCI, predominantly target vessel revascularization (TVR) was higher in long CTO group. In multivariate analysis, long CTO was an important predictor for repeat PCI (OR;4.26, CI 1.53-11.9, p=0.006). Conclusion: The safety profile, angiographic and 2-year clinical outcomes were similar between the two groups except higher incidence of repeat PCI in long CTO group despite of successful PCI with DESs.

8 September 2023 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
JAJihun Ahn
Jihun Ahn
HYHyeYon Yu
HyeYon Yu
SRSeung-Woon Rha
Seung-Woon Rha
BCByoung Geol Choi
Byoung Geol Choi
SPSoohyung Park
Soohyung Park
CCCheol Ung Choi
Cheol Ung Choi